Catalyst Wire Dossier Catalyst Wire Dossier

Avian Flu Vaccine 1557484A

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Avian Flu Vaccine 1557484A, covering 2014-09-04 to 2014-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years [Phase 2]

See pricing